The prognostic implications of cuproptosis‐related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma
Pigment Cell & Melanoma Research · 2024
DOI: 10.1111/pcmr.13185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2024. Verfasst von Bin Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Dawn Project in Special Project of Knowledge Innovation of Wuhan.
Abstract (Originalsprache)
Cutaneous melanoma is the most lethal of all skin tumors. Recently, cuproptosis, a novel form of cell death linked to oxidative phosphorylation, has emerged as an important factor. However, the precise role of cuproptosis in melanoma remains unclear. Our research explored the potential links between cuproptosis‐related genes, prognosis, immune microenvironments, and melanoma treatments. Significantly, cuproptosis regulators showed remarkable differences between melanoma and normal tissues, establishing their relevance to melanoma. The newly developed cuproptosis‐related gene signature (CGS) demonstrated a robust ability to predict overall survival (OS) in melanoma. We constructed a novel nomogram that combined clinical features with CGS to improve predictive accuracy. In addition, the study revealed correlations between CGS and immune cell populations, including CD8 + T cells, Tfh cells, B cells, and myeloid‐derived suppressor cells. Within the CGS, Peptidylprolyl isomerase C (PPIC) emerged as the most strongly associated with poor prognosis and drug resistance in melanoma. PPIC was identified as a promoter of melanoma progression, enhancing cell invasiveness while concurrently suppressing CD8 + T cell activation. This comprehensive study not only elucidated the intricate connections between CGS, melanoma prognosis, immune microenvironment, and drug resistance but also provided compelling evidence supporting PPIC as a promising biomarker for predicting OS in melanoma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China.
- Hubei Engineering Research Center of Skin Disease Theranostics and Health, Wuhan, China.
Förderung
- National Natural Science Foundation of China
- Dawn Project in Special Project of Knowledge Innovation of Wuhan
Zitieren
APA
Zhou, B., Sha, S., Wang, Q., Sun, S., Tao, J., Zhu, J., & Dong, L. (2024). The prognostic implications of cuproptosis‐related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13185
Vancouver
Zhou B, Sha S, Wang Q, Sun S, Tao J, Zhu J, et al. The prognostic implications of cuproptosis‐related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma. Pigment Cell & Melanoma Research. 2024. doi:10.1111/pcmr.13185
BibTeX
@article{Zhou2024,
author = {Zhou, Bin and Sha, Shanshan and Wang, Qi and Sun, Shuomin and Tao, Juan and Zhu, Jinjin and Dong, Liyun},
title = {The prognostic implications of cuproptosis‐related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma},
journal = {Pigment Cell & Melanoma Research},
year = {2024},
doi = {10.1111/pcmr.13185}
}
EUVIMED